AGNC vs EGP

AGNC exhibits severe financial health concerns, as evidenced by a Piotroski F-Score of 3/9 (indicating weak fundamentals) and a missing Altman Z-Score, which raises unquantified distress risk. Despite a high intrinsic value estimate of $43.37 and a Graham Number of $17.64, the stock trades at $10.23, suggesting a potential undervaluation—however, this is undermined by extreme leverage (Debt/Equity: 6.89), near-zero liquidity (Current Ratio: 0.18), and a 97.96% payout ratio. The recent insider selling of $11.43M over six months signals strong bearish sentiment, while earnings have consistently missed expectations in the last four quarters. The 52-week range of $7.85–$12.19 reflects high volatility and lack of sustained momentum.

EGP presents a dichotomy between strong operational performance and stretched valuation. While the Piotroski F-Score of 4/9 indicates stable financial health, the stock trades at a significant premium to its Graham Number ($90.13) and Intrinsic Value ($162.25). Robust earnings growth (55.3% YoY) is offset by a critical red flag: a dividend payout ratio of 110%, which is unsustainable in the long term. Despite bullish analyst targets, the high PEG ratio and bearish insider sentiment suggest limited immediate upside.